CLINICAL_TRIALS
research
· 2024-05-28
Clinical Trial Update: Nephroprotective Effect of Nicorandil in Type 2 Diabetes Mellitus [Phase 3]
Summary
A Phase 3 clinical trial sponsored by Tanta University is evaluating the nephroprotective effects of nicorandil in type 2 diabetes mellitus, and it is currently…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanta University | Conditions: Type2 Diabetes Mellitus | Phase 3 | Status: RECRUITING